Larry Rigby, ZARS Pharma
Larry D. Rigby is a cofounder of ZARS Pharma and served as its Chief Executive Officer from inception to January 2006. He has been a member of the board of directors since inception and is currently Vice Chairman. Prior to co-founding ZARS, Mr. Rigby was President and founder of MicroJect, a medical device company, which was acquired in 1998 by Sorenson Development. In August 1986 he founded and served as Chief Executive Officer of CardioPulmonics, a medical device company. From August 1985 to June 1995 he was Chairman and founder of Alton Dean Medical, which was acquired by Mallinckrodt Medical in June 1995. From August 1982 to August 1985, he was President of Martin U.S.A.
Mr. Rigby started his career with Sorenson Research Company in August 1975 where he was Vice President of Sales and Marketing. Currently, he is Chairman and Chief Executive Officer of Larada Sciences and Chairman of Exeven Therapeutics. Mr. Rigby has a B.A. from Idaho State University and an M.A. from the University of Kansas. In 2006, Idaho State University honored Larry with its Distinguished Alumni Award.